Wound and mucous membrane disinfectant
    1.
    发明授权
    Wound and mucous membrane disinfectant 有权
    伤口和粘膜消毒剂

    公开(公告)号:US08465766B2

    公开(公告)日:2013-06-18

    申请号:US13236847

    申请日:2011-09-20

    IPC分类号: A61K9/66

    摘要: Aqueous wound and mucous membrane disinfectant containing a) octenidine dihydrochloride, and b) one or more active ingredients selected from the group ethanol, 1-propanol, 2-propanol, undecylene amidopropyl trimonium methosulfate, 3-(4-chlorophenoxy)-1,2-propanediol and/or sodium hydroxymethylglycinate and c) glycerin and/or 1,2-diols having 3 to 10 carbon atoms, and d) optionally surfactants, emulsifiers, solubilizers, pH regulators, dyestuffs, perfumes and/or thickeners, the agent being free of phenoxyethanol, phenoxypropanol, phenoxyisopropanol and organic acids.

    摘要翻译: 含有a)奥氮平二盐酸盐的水性伤口和粘膜消毒剂,和b)一种或多种选自乙醇,1-丙醇,2-丙醇,十一烷基氨基丙基三甲基甲硫酸盐,3-(4-氯苯氧基)-1,2 - 丙二醇和/或羟甲基甘氨酸钠,和c)具有3-10个碳原子的甘油和/或1,2-二醇,和d)任选的表面活性剂,乳化剂,增溶剂,pH调节剂,染料,香料和/或增稠剂, 不含苯氧基乙醇,苯氧基丙醇,苯氧基异丙醇和有机酸。

    WOUND AND MUCOUS MEMBRANE DISINFECTANT
    2.
    发明申请
    WOUND AND MUCOUS MEMBRANE DISINFECTANT 有权
    创面和不透明膜消毒剂

    公开(公告)号:US20120070510A1

    公开(公告)日:2012-03-22

    申请号:US13236847

    申请日:2011-09-20

    IPC分类号: A61K33/42 A61P31/00 A61K33/00

    摘要: Aqueous wound and mucous membrane disinfectant containing a) octenidine dihydrochloride, and b) one or more active ingredients selected from the group ethanol, 1-propanol, 2-propanol, undecylene amidopropyl trimonium methosulfate, 3-(4-chlorophenoxy)-1,2-propanediol and/or sodium hydroxymethylglycinate and c) glycerin and/or 1,2-diols having 3 to 10 carbon atoms, and d) optionally surfactants, emulsifiers, solubilisers, pH regulators, dyestuffs, perfumes and/or thickeners, the agent being free of phenoxyethanol, phenoxypropanol, phenoxyisopropanol and organic acids.

    摘要翻译: 含有a)奥氮平二盐酸盐的水性伤口和粘膜消毒剂,和b)一种或多种选自乙醇,1-丙醇,2-丙醇,十一烷基氨基丙基三甲基甲硫酸盐,3-(4-氯苯氧基)-1,2 丙二醇和/或羟甲基甘氨酸钠,和c)具有3-10个碳原子的甘油和/或1,2-二醇,和d)任选的表面活性剂,乳化剂,增溶剂,pH调节剂,染料,香料和/或增稠剂, 不含苯氧基乙醇,苯氧基丙醇,苯氧基异丙醇和有机酸。

    WOUND AND MUCOUS MEMBRANE DISINFECTANT
    3.
    发明申请
    WOUND AND MUCOUS MEMBRANE DISINFECTANT 审中-公开
    创面和不透明膜消毒剂

    公开(公告)号:US20090076084A1

    公开(公告)日:2009-03-19

    申请号:US12064746

    申请日:2006-07-31

    IPC分类号: A01N43/40 A01P1/00

    摘要: Aqueous wound and mucous membrane disinfectant containing a) octenidine dihydrochloride, and b) one or more active ingredients selected from the group ethanol, 1-propanol, 2-propanol, undecylene amidopropyl trimonium methosulfate, 3-(4-chlorophenoxy)-1,2-propanediol and/or sodium hydroxymethylglycinate and c) glycerin and/or 1,2-diols having 3 to 10 carbon atoms, and d) optionally surfactants, emulsifiers, solubilisers, pH regulators, dyestuffs, perfumes and/or thickeners, the agent being free of phenoxyethanol, phenoxypropanol, phenoxyisopropanol and organic acids.

    摘要翻译: 含有a)奥氮平二盐酸盐的水性伤口和粘膜消毒剂,和b)一种或多种选自乙醇,1-丙醇,2-丙醇,十一烷基氨基丙基三甲基甲硫酸盐,3-(4-氯苯氧基)-1,2 丙二醇和/或羟甲基甘氨酸钠,和c)具有3-10个碳原子的甘油和/或1,2-二醇,和d)任选的表面活性剂,乳化剂,增溶剂,pH调节剂,染料,香料和/或增稠剂, 不含苯氧基乙醇,苯氧基丙醇,苯氧基异丙醇和有机酸。

    Inositol polyphosphate derivatives and methods of using same
    5.
    发明授权
    Inositol polyphosphate derivatives and methods of using same 失效
    肌醇多磷酸衍生物及其使用方法

    公开(公告)号:US5977078A

    公开(公告)日:1999-11-02

    申请号:US934450

    申请日:1997-09-19

    IPC分类号: C07F9/117 A61K31/70

    摘要: The present invention provides compositions that are cell permeable antagonists of inositol polyphosphates. In addition, the invention provides methods for enhancing chloride ion secretion from a cell by contacting the cells with cell permeable antagonists of inositol polyphosphates. The invention also provides methods for enhancing chloride ion secretion in an individual by administering cell permeable antagonists of inositol polyphosphates to the individual. The invention additionally provides methods for alleviating a sign or symptom associated with cystic fibrosis in an individual by administering a cell permeable antagonist of inositol polyphosphates to the individual. The invention also provides compositions that are cell permeable agonists of inositol polyphosphates. In addition, the invention provides methods for decreasing chloride ion secretion from a cell by contacting the cell with cell permeable agonists of inositol polyphosphates. The invention also provides methods for decreasing chloride ion secretion in an individual by administering cell permeable agonists of inositol polyphosphates to the individual. The invention additionally provides methods for alleviating a sign or symptom associated with secretory diarrhea in an individual by administering cell permeable agonists of inositol polyphosphates to the individual.

    摘要翻译: 本发明提供了作为肌醇多磷酸盐的细胞渗透性拮抗剂的组合物。 此外,本发明提供了通过使细胞与肌醇多磷酸盐的细胞可渗透的拮抗剂接触来提高细胞中氯离子分泌的方法。 本发明还提供了通过向个体施用肌醇多磷酸盐的细胞可渗透的拮抗剂来增强个体中的氯离子分泌的方法。 本发明还提供了通过向个体施用肌醇多磷酸盐的细胞可渗透拮抗剂来减轻个体中与囊性纤维化相关的征兆或症状的方法。 本发明还提供了作为肌醇多磷酸盐的细胞渗透性激动剂的组合物。 此外,本发明提供了通过使细胞与肌醇多磷酸盐的细胞可渗透的激动剂接触来减少细胞的氯离子分泌的方法。 本发明还提供通过向个体施用肌醇多磷酸盐的细胞可渗透的激动剂来减少个体中的氯离子分泌的方法。 本发明另外提供了通过向个体施用肌醇多磷酸盐的细胞可渗透的激动剂来减轻个体中与分泌性腹泻相关的征兆或症状的方法。

    Inositol polyphosphates and methods of using same
    6.
    发明授权
    Inositol polyphosphates and methods of using same 失效
    肌醇多磷酸盐及其使用方法

    公开(公告)号:US5880099A

    公开(公告)日:1999-03-09

    申请号:US926831

    申请日:1997-09-10

    IPC分类号: C07F9/117 A61K31/70

    摘要: The present invention provides compositions that are cell permeable antagonists of inositol polyphosphates. In addition, the invention provides methods for enhancing chloride ion secretion from a cell by contacting the cells with cell permeable antagonists of inositol polyphosphates. The invention also provides methods for enhancing chloride ion secretion in an individual by administering cell permeable antagonists of inositol polyphosphates to the individual. The invention additionally provides methods for alleviating a sign or symptom associated with cystic fibrosis in an individual by administering a cell permeable antagonist of inositol polyphosphates to the individual. The invention also provides compositions that are cell permeable agonists of inositol polyphosphates. In addition, the invention provides methods for decreasing chloride ion secretion from a cell by contacting the cell with cell permeable agonists of inositol polyphosphates. The invention also provides methods for decreasing chloride ion secretion in an individual by administering cell permeable agonists of inositol polyphosphates to the individual. The invention additionally provides methods for alleviating a sign or symptom associated with secretory diarrhea in an individual by administering cell permeable agonists of inositol polyphosphates to the individual.

    摘要翻译: 本发明提供了作为肌醇多磷酸盐的细胞渗透性拮抗剂的组合物。 此外,本发明提供了通过使细胞与肌醇多磷酸盐的细胞可渗透的拮抗剂接触来提高细胞中氯离子分泌的方法。 本发明还提供了通过向个体施用肌醇多磷酸盐的细胞可渗透的拮抗剂来增强个体中的氯离子分泌的方法。 本发明还提供了通过向个体施用肌醇多磷酸盐的细胞可渗透拮抗剂来减轻个体中与囊性纤维化相关的征兆或症状的方法。 本发明还提供了作为肌醇多磷酸盐的细胞渗透性激动剂的组合物。 此外,本发明提供了通过使细胞与肌醇多磷酸盐的细胞可渗透的激动剂接触来减少细胞中氯离子分泌的方法。 本发明还提供通过向个体施用肌醇多磷酸盐的细胞可渗透的激动剂来减少个体中的氯离子分泌的方法。 本发明另外提供了通过向个体施用肌醇多磷酸盐的细胞可渗透的激动剂来减轻个体中与分泌性腹泻相关的征兆或症状的方法。